Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

MediWound Ltd. (MDWD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
14.01-0.11 (-0.78%)
At close: 03:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close14.12
Open14.00
Bid12.00 x 1100
Ask14.21 x 1300
Day's Range13.50 - 14.55
52 Week Range8.05 - 17.25
Volume48,993
Avg. Volume61,733
Market Cap81.529M
Beta (5Y Monthly)1.00
PE Ratio (TTM)N/A
EPS (TTM)-0.52
Earnings DateMar 15, 2023 - Mar 20, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est40.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MDWD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MediWound Ltd.
    Daily – Vickers Top Insider Picks for 12/30/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • TipRanks

    Buy These 2 Stocks Before They Jump Over 80%, Say Analysts

    The latest Consumer Price Index (CPI) figures showed that inflation is still easing, having dropped for the 6th consecutive month. The CPI for December rose by 6.5% from the same period a year ago and fell by 0.1% compared to November, thereby meeting Street expectations. There are still areas of concern, though, such as services inflation, which might put a spanner in the works for investors hoping the latest readout will cause the Fed to put the brakes on its rate-hiking endeavors. Additionall

  • Simply Wall St.

    MediWound (NASDAQ:MDWD) investors are sitting on a loss of 61% if they invested five years ago

    This month, we saw the MediWound Ltd. ( NASDAQ:MDWD ) up an impressive 39%. But that is little comfort to those holding...

  • Benzinga

    FDA Approves MediWound's NexoBrid For Burn Treatment

    The FDA has approved MediWound Ltd's (NASDAQ: MDWD) NexoBrid (anacaulase-bcdb) to remove eschar in adults with deep partial-thickness and/or full-thickness thermal burns. NexoBrid, a botanical drug product containing proteolytic enzymes, is already approved in 43 countries. Recently, MediWound signed an agreement with Triskel Integrated Services to market and distribute NexoBrid in Switzerland, with a launch planned for Q1 of 2023. Triskel also holds the distribution rights of NexoBrid in France

Advertisement
Advertisement